| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |